These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 7949207

  • 1. Second generation aromatase inhibitor--4-hydroxyandrostenedione.
    Dowsett M, Coombes RC.
    Breast Cancer Res Treat; 1994; 30(1):81-7. PubMed ID: 7949207
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Aromatization inhibition alone or in combination with GnRH agonists for the treatment of premenopausal breast cancer patients.
    Dowsett M, Stein RC, Coombes RC.
    J Steroid Biochem Mol Biol; 1992 Sep; 43(1-3):155-9. PubMed ID: 1388047
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Plasma and urinary oestrogens in breast cancer patients on treatment with 4-hydroxyandrostenedione.
    Johannessen DC, Adlercreutz H, Fotsis T, Lønning PE.
    Br J Cancer; 1993 Aug; 68(2):393-8. PubMed ID: 8135918
    [Abstract] [Full Text] [Related]

  • 8. Aromatase inhibitors and their use in the sequential setting.
    Coombes RC, Harper-Wynne C, Dowsett M.
    Endocr Relat Cancer; 1999 Jun; 6(2):259-63. PubMed ID: 10731118
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. 4-Hydroxyandrostenedione in treatment of postmenopausal patients with advanced breast cancer.
    Coombes RC, Goss P, Dowsett M, Gazet JC, Brodie A.
    Lancet; 1984 Dec 01; 2(8414):1237-9. PubMed ID: 6150277
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Treatment of advanced postmenopausal breast cancer with an aromatase inhibitor, 4-hydroxyandrostenedione: phase II report.
    Goss PE, Powles TJ, Dowsett M, Hutchison G, Brodie AM, Gazet JC, Coombes RC.
    Cancer Res; 1986 Sep 01; 46(9):4823-6. PubMed ID: 2942241
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. An endocrine and pharmacokinetic study of four oral doses of formestane in postmenopausal breast cancer patients.
    Dowsett M, Mehta A, King N, Smith IE, Powles TJ, Stein RC, Coombes RC.
    Eur J Cancer; 1992 Sep 01; 28(2-3):415-20. PubMed ID: 1591054
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.